LMAT Financials Lemaitre Vascular Inc

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Aug 9, 2026, 10:13 UTC Overview →

Growth & profitability

Revenue has grown 14.0% per year over the past 5 years.
Net income has grown faster than revenue (22.1% vs 14.0% per year).
Operating margin has expanded, at 27.2% in the latest year.
Free cash flow has grown 18.5% per year over the past 5 years.

Financial health

Operating income covered interest expense 13× in the latest year, down from 22× 5 years ago.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 31.4% of earnings and 24.3% of free cash flow.
The dividend has grown 18.7% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$250M	$58M	71.5%	27.2%	14.7%	9.4%	$74M	—	$28M
2024	$220M	$44M	68.6%	23.8%	13.0%	8.0%	$37M	—	$26M
2023	$193M	$30M	65.7%	19.0%	10.1%	8.7%	$29M	—	$24M
2022	$162M	$21M	64.9%	16.6%	7.7%	6.6%	$22M	—	$19M
2021	$154M	$27M	65.7%	23.6%	10.6%	9.2%	$30M	—	$14M
2020	$129M	$21M	65.4%	22.3%	12.3%	8.4%	$32M	—	$27M
2019	$117M	$18M	68.1%	18.1%	12.1%	9.5%	$10M	—	$12M
2018	$106M	$23M	70.0%	26.7%	17.6%	15.0%	$16M	—	$26M
2017	$101M	$17M	70.1%	20.9%	15.6%	13.6%	$16M	—	$19M
2016	—	$11M	—	—	12.1%	10.4%	$14M	—	$24M
2015	—	$8M	—	—	10.0%	8.6%	—	—	$27M
2014	—	$4M	—	—	5.7%	4.8%	—	—	$19M
2013	—	$3M	—	—	5.7%	4.5%	—	—	$15M
2012	—	$3M	—	—	4.9%	4.1%	—	—	$16M
2011	—	$2M	—	—	4.1%	3.6%	—	—	$20M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$70M	$17M	72.1%	29.0%	4.1%	2.7%	$14M	—	$27M
Mar '26	$67M	$16M	72.7%	26.7%	3.9%	2.5%	$12M	—	$27M
Dec '25	$64M	$16M	71.7%	29.2%	4.0%	2.5%	$21M	—	$28M
Sep '25	$61M	$17M	75.3%	33.3%	4.6%	2.9%	$26M	—	$25M
Jun '25	$64M	$14M	70.0%	25.1%	3.8%	2.4%	$19M	—	$27M
Mar '25	$60M	$11M	69.2%	21.1%	3.2%	2.0%	$8M	—	$25M
Dec '24	$56M	$11M	69.3%	23.1%	3.3%	2.0%	$13M	—	$26M
Sep '24	$55M	$11M	67.8%	24.0%	3.4%	3.0%	$13M	—	$21M
Jun '24	$56M	$12M	68.9%	25.7%	3.7%	3.3%	$8M	—	$22M
Mar '24	$53M	$10M	68.6%	22.2%	3.2%	2.8%	$4M	—	$27M
Dec '23	$49M	$8M	68.1%	20.9%	2.8%	2.4%	$9M	—	$24M
Sep '23	$47M	$8M	65.0%	19.4%	2.6%	2.2%	$11M	—	$18M
Jun '23	$50M	$8M	64.0%	18.9%	2.9%	2.5%	$9M	—	$19M
Mar '23	$47M	$6M	65.6%	16.7%	2.2%	1.9%	$149000	—	$17M
Dec '22	$41M	$6M	63.6%	17.0%	2.1%	1.8%	$3M	—	$19M
Sep '22	$39M	$5M	64.2%	15.8%	2.1%	1.8%	$7M	—	$17M
Jun '22	$42M	$4M	66.0%	13.7%	1.4%	1.2%	$8M	—	$21M
Mar '22	$40M	$6M	65.6%	20.0%	2.3%	2.1%	$4M	—	$16M
Dec '21	$40M	$6M	65.7%	21.0%	2.4%	2.1%	$4M	—	$14M
Sep '21	$38M	$7M	64.8%	23.6%	2.6%	2.2%	$12M	—	$17M

Valuation over time

How the market has priced LMAT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 57.1× (Mar '23) to 32.2× (Nov '26).
The price-to-sales ratio has risen from 7.3× (Mar '23) to 7.4× (Nov '26).
The dividend yield has risen from 0.9% (Mar '23) to 1.0% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is LMAT growing its revenue and profit?

Over the past 5 years, Lemaitre Vascular Inc's revenue has grown 14.0% per year, and net income grown 22.1% per year. These are computed facts, not advice.

How much debt does LMAT have?

As of FY2025, Lemaitre Vascular Inc reported — of total debt against $28M of cash; operating income covered interest expense 13×.

What is LMAT's profit margin?

In FY2025, gross margin was 71.5%, operating margin 27.2%, and net margin 23.1%.

What is LMAT's P/E ratio?

Lemaitre Vascular Inc's P/E (TTM) is 28.29 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the LMAT stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 32.2× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.